Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
28.29
+0.53 (1.91%)
At close: Jul 24, 2026, 4:00 PM EDT
27.87
-0.42 (-1.48%)
After-hours: Jul 24, 2026, 7:46 PM EDT
Faeth Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
29
Market Cap
729.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionFTH News
- 2 days ago - Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 days ago - Faeth Therapeutics initiated with an Outperform at Citizens - TheFly
- 10 days ago - Faeth Therapeutics, Inc trading resumes - TheFly
- 10 days ago - Faeth Therapeutics, Inc trading halted, volatility trading pause - TheFly
- 4 weeks ago - Faeth Therapeutics initiated with an Outperform at Baird - TheFly
- 4 weeks ago - Faeth Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 5 weeks ago - Faeth Therapeutics files automatic mixed securities shelf - TheFly
- 5 weeks ago - Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer - Business Wire